CDIO 8-K — Smart Summary
78% reductionOn October 15, 2025, Cardio Diagnostics Holdings, Inc. held its annual meeting of stockholders. Of 1,763,129 shares eligible to vote as of the August 25, 2025 record date, 927,526 shares (approximately 52.6%) were present or represented by proxy, and stockholders voted on three proposals.
Item 5.07 — Submission of Matters to a Vote of Security Holders
Director Elections
- Meeshanthini V. Dogan — 361,246 for / 103,733 withheld (77.7% approval)
- Warren Hosseinion — 429,765 for / 35,214 withheld (92.4% approval)
- Wendy J. Betts — 355,919 for / 109,060 withheld (76.5% approval)
- Paul F. Burton — 428,090 for / 36,889 withheld (92.1% approval)
- Peter K. Fung — 433,252 for / 31,727 withheld (93.2% approval)
- James Intrater — 427,266 for / 37,713 withheld (91.9% approval)
- Robert Philibert — 431,160 for / 33,819 withheld (92.7% approval)
Management Proposals
- Share Issuance Proposal (approval of future issuance of shares of Common Stock and/or securities convertible into or exercisable for Common Stock equal to 20% or more of Common Stock outstanding in one or more non-public transactions per Nasdaq Marketplace Listing Rule 5635(d)) — 283,304 for / 166,492 against / 15,183 abstain (61.9% approval) — passed
- Auditor Ratification Proposal (ratification of appointment of Prager Metis CPA's LLC as independent registered public accounting firm for fiscal year ending December 31, 2025) — 813,401 for / 64,820 against / 49,305 abstain (87.2% approval) — passed
§ MORE SUMMARIES
More CDIO Smart Summaries
Other filings for Cardio Diagnostics Holdings, Inc. with a Smart Summary.
8-K$CDIOCardio Diagnostics Holdings, Inc.Smart Summary
8-K Filing
AI-powered cardiac diagnostic tests target $176B U.S. market
8-K$CDIOCardio Diagnostics Holdings, Inc.Smart Summary
8-K Filing
Stock regains Nasdaq compliance after reaching $1.00 minimum bid price
8-K$CDIOCardio Diagnostics Holdings, Inc.Smart Summary
8-K Filing
1-for-30 reverse stock split effective immediately
8-K$CDIOCardio Diagnostics Holdings, Inc.Smart Summary
8-K Filing
Investor presentation highlights $300B cardiovascular market opportunity
8-K$CDIOCardio Diagnostics Holdings, Inc.Smart Summary
8-K Filing
Nasdaq grants second 180-day extension to regain minimum bid price compliance
8-K$CDIOCardio Diagnostics Holdings, Inc.Smart Summary
8-K Filing
Stockholders approve director slate, reverse split, and auditor ratification
8-K$CDIOCardio Diagnostics Holdings, Inc.Smart Summary
8-K Filing
Stock price falls below $1 minimum bid requirement
8-K$CDIOCardio Diagnostics Holdings, Inc.Smart Summary
8-K Filing
AI-driven cardiovascular tests target $300B market amid commercial expansion
Never miss a CDIO filing
Get real-time email alerts when CDIO files with the SEC.